SUPN
Supernus Pharmaceuticals Inc
Price:  
29.72 
USD
Volume:  
2,063,171.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SUPN DCF Valuation - Growth Exit 5Y

68.7%
Upside

What is the DCF valuation of SUPN??

The Discounted Cash Flow (DCF) valuation of Supernus Pharmaceuticals Inc (SUPN) is 50.13 USD. With the latest stock price at 29.72 USD, the upside of Supernus Pharmaceuticals Inc based on DCF is 68.7%.

Is SUPN a buy or a sell?

Based on the latest price of 29.72 USD and our DCF valuation, Supernus Pharmaceuticals Inc (SUPN) is a buy. buying SUPN stocks now will result in a potential gain of 68.7%.

Range Selected
WACC / Discount Rate 5.9% - 7.9% 6.9%
Long-term Growth Rate 3.0% - 5.0% 4.0%
Fair Price 30.21 - 160.17 50.13
Upside 1.6% - 438.9% 68.7%
29.72 USD
Stock Price
50.13 USD
Fair Price